-
EP2448637
European procedure
Extract from the Register of European Patents
EP About this file: EP2448637
| EP2448637 - USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 06.05.2022 Database last updated on 02.11.2024 | Most recent event Tooltip | 06.05.2022 | Patent maintained (B2 publication) | published on 08.06.2022 [2022/23] | Applicant(s) | For all designated states GW Pharma Limited Sovereign House Histon Cambridge CB24 9BZ / GB | For all designated states Otsuka Pharmaceutical Co. Limited 9, Kanda-Tsukasamachi 2-chome Chiyoda-ku Tokyo 101-8535 / JP | [2022/23] |
| Former [2015/18] | For all designated states GW Pharma Limited Sovereign House Histon Cambridge CB24 9BZ / GB | ||
| For all designated states Otsuka Pharmaceutical Co. Limited 9, Kanda-Tsukasamachi 2-chome Chiyoda-ku Tokyo 101-8535 / JP | |||
| Former [2014/11] | For all designated states GW Pharma Limited Porton Down Science Park Salisbury Wiltshire SP4 0JQ / GB | ||
| For all designated states Otsuka Pharmaceutical Co. Limited 9, Kanda-Tsukasamachi 2-chome Chiyoda-ku Tokyo 101-8535 / JP | |||
| Former [2012/19] | For all designated states GW Pharma Limited Porton Down Science Park Salisbury Wiltshire SP4 0JR / GB | ||
| For all designated states Otsuka Pharmaceutical Co., Ltd. 9, Kanda-Tsukasa-machi 2-chome Chiyoda-ku Tokyo 101-8535 / JP | Inventor(s) | 01 /
WHALLEY, Ben School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | 02 /
STEPHENS, Gary School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | 03 /
WILLIAMS, Claire School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | 04 /
GUY, Geoffrey GW Pharmaceuticals Limited Porton Down Science Park Salisbury SP4 0JQ / GB | 05 /
WRIGHT, Stephen GW Pharmaceuticals Limited Porton Down Science Park Salisbury SP4 0JQ / GB | 06 /
KIKUCHI, Tetsuro Otsuka Pharmaceutical Company Limited 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 5410045 / JP | [2014/11] |
| Former [2012/19] | 01 /
WHALLEY, Ben School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | ||
| 02 /
STEPHENS, Gary School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | |||
| 03 /
WILLIAMS, Claire School of Pharmacy University of Reading Whiteknights PO Box 226 Reading RG6 6AP / GB | |||
| 04 /
GUY, Geoffrey GW Pharmaceuticals Limited Porton Down Science Park Salisbury SP4 0JQ / GB | |||
| 05 /
WRIGHT, Stephen GW Pharmaceuticals Limited Porton Down Science Park Salisbury SP4 0JQ / GB | |||
| 06 /
KIKUCHI, Tetsuro Otsuka Pharmaceutical Company Limited 1-7-1, Doshomaohi Chuo-ku Osaka-shi Osaka 6410045 / JP | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2022/23] |
| Former [2014/07] | Wells, Andrew, et al Harrison Goddard Foote LLP 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | ||
| Former [2012/19] | Harrison Goddard Foote 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 10734541.5 | 29.06.2010 | [2022/23] | WO2010GB51066 | Priority number, date | GB20090011580 | 03.07.2009 Original published format: GB 0911580 | [2012/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011001169 | Date: | 06.01.2011 | Language: | EN | [2011/01] | Type: | A1 Application with search report | No.: | EP2448637 | Date: | 09.05.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.01.2011 takes the place of the publication of the European patent application. | [2012/19] | Type: | B1 Patent specification | No.: | EP2448637 | Date: | 12.03.2014 | Language: | EN | [2014/11] | Type: | B2 New European patent specification | No.: | EP2448637 | Date: | 08.06.2022 | Language: | EN | [2022/23] | Search report(s) | International search report - published on: | EP | 06.01.2011 | Classification | IPC: | A61P25/08, A61K31/352 | [2012/19] | CPC: |
A61K31/05 (EP,CN,GB,KR,US);
A61K31/658 (KR);
A61K31/352 (EP,CN,GB,KR,US);
A61K36/185 (GB,KR);
A61K9/0019 (KR);
A61P25/00 (EP);
A61P25/08 (EP,KR);
A61P25/10 (EP);
A61P25/12 (EP);
| C-Set: |
A61K31/05, A61K2300/00 (CN);
A61K31/352, A61K2300/00 (CN) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/19] | Title | German: | VERWENDUNG EINES PHYTOCANNABINOIDS ODER EINER KOMBINATION AUS PHYTOCANNABINOIDEN ZUR BEHANDLUNG VON EPILEPSIE | [2012/19] | English: | USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY | [2012/19] | French: | UTILISATION D'UN PHYTO-CANNABINOIDE OU D'UNE COMBINAISON DE PHYTO-CANNABINOIDES DANS LE TRAITEMENT DE L'EPILEPSIE | [2012/19] | Entry into regional phase | 31.01.2012 | National basic fee paid | 31.01.2012 | Designation fee(s) paid | 31.01.2012 | Examination fee paid | Examination procedure | 03.05.2011 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 31.01.2012 | Examination requested [2012/19] | 23.10.2012 | Despatch of a communication from the examining division (Time limit: M04) | 15.02.2013 | Reply to a communication from the examining division | 01.10.2013 | Communication of intention to grant the patent | 31.01.2014 | Fee for grant paid | 31.01.2014 | Fee for publishing/printing paid | 03.04.2017 | Observations by third parties | 04.02.2020 | Observations by third parties | Divisional application(s) | EP14153495.8 / EP2727626 | EP20175934.7 / EP3718603 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.10.2012 | Opposition(s) | Opponent(s) | 01
05.12.2014
10.12.2014
ADMISSIBLE Insys Therapeutics, Inc. 1333 South Spectrum Blvd, Suite 100 Chandler, AZ 85286 / US Opponent's representative Carpmaels & Ransford LLP, et al, et al One Southampton Row London WC1B 5HA / GB | [2021/37] |
| Former [2021/10] | |||
| Opponent(s) | 01
05.12.2014
10.12.2014
ADMISSIBLE Insys Therapeutics, Inc. 1333 South Spectrum Blvd, Suite 100 Chandler, AZ 85286 / US Opponent's representative Goodfellow, Hugh Robin, et al, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | ||
| Former [2018/52] | |||
| Opponent(s) | 01
05.12.2014
10.12.2014
ADMISSIBLE Insys Therapeutics, Inc. 1333 South Spectrum Blvd, Suite 100 Chandler, AZ 85286 / US Opponent's representative Elkington & Fife LLP, et al, et al Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | ||
| Former [2015/03] | |||
| Opponent(s) | 01
05.12.2014
10.12.2014
ADMISSIBLE Insys Therapeutics, Inc. 1333 South Spectrum Blvd, Suite 100 Chandler, AZ 85286 / US Opponent's representative Kingsbury, Oliver William, et al, et al Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | 20.01.2015 | Invitation to proprietor to file observations on the notice of opposition | 29.05.2015 | Reply of patent proprietor to notice(s) of opposition | 10.11.2016 | Date of oral proceedings | 15.12.2016 | Despatch of interlocutory decision in opposition | 15.12.2016 | Despatch of minutes of oral proceedings | 14.10.2021 | Legal effect of interlocutory decision in opposition | 31.01.2022 | Despatch of communication that the patent will be maintained as amended | 28.04.2022 | Fee for printing new specification paid | Appeal following opposition | 05.12.2016 | Appeal received No. T0007/17 | 21.04.2017 | Statement of grounds filed | 14.10.2021 | Result of appeal procedure: appeal of the opponent was rejected | 12.01.2022 | Despatch of the decision of the Board of Appeal | 14.02.2017 | Appeal received No. T0007/17 | 13.04.2017 | Statement of grounds filed | 06.07.2021 | Invitation to file observations in an appeal (Time limit: M02) [2021/28] | 16.09.2021 | Date of receipt of observations in an appeal [2021/38] | 14.10.2021 | Result of appeal procedure: appeal of the opponent was rejected | 12.01.2022 | Despatch of the decision of the Board of Appeal | 14.10.2021 | Date of oral proceedings | Fees paid | Renewal fee | 31.03.2012 | Renewal fee patent year 03 | 02.04.2013 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 12.03.2014 | MK | 12.03.2014 | SM | 12.03.2014 | [2018/46] |
| Former [2018/30] | MK | 12.03.2014 | |
| SM | 12.03.2014 | ||
| Former [2016/22] | SM | 12.03.2014 | Cited in | International search | [A]WO2004016246 (GW PHARMA LTD [GB], et al); | [A]US2006039959 (WESSLING WERNER [DE]); | [A]WO2006054057 (GW PHARMA LTD [GB], et al); | [A]WO2009007697 (GW PHARMA LTD [GB], et al); | by applicant | WO02064109 | WO2004016277 | WO2006054057 | WO2009007697 |